newsfilter
← Latest News
PR Newswire·

INOVIO Announces Pricing of $20.0 Million Public Offering

INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect ...